[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607150":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":33,"collaborators":10,"id":37,"slug":10,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":10,"enrollmentInfo":45,"targetDuration":10,"studyType":48,"phases":10,"briefSummary":49,"conditions":50,"keywords":10,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"TAK-PAI group",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Wanmu Xie, Doctor","CONTACT","15611734410","xiewanmu@126.com",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"China-Japan Friendship hospital","RECRUITING","Beijing","Beijing Municipality","100029","China",{"type":26,"coordinates":27},"Point",[28,29],116.39723,39.9075,{"lat":29,"lon":28},[32],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Wanmu Xie","Director, Department of Integrative Pulmonary Medicine","100607150",false,"NCT07184814","Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement","CAPTAIN","Inclusion Criteria:\n\n* Hospitalized between Jan 1, 2016 and Dec 31, 2026\n* Diagnosed with TAK according to the modified Ishikawa criteria and\u002For 1990 American College of Rheumatology criteria and\u002For 2022 ACR\u002FEULAR criteria\n* Diagnosed with pulmonary artery involvement using computed tomography pulmonary angiography or transcatheter pulmonary angiography\n* Patients without aortic or primary branch involvement who nonetheless exhibited both clinical features and computed tomography-confirmed evidence of pulmonary artery involvement (PAI), after exclusion of other diseases causing pulmonary artery stenosis or occlusion\n\nExclusion Criteria:\n\n* Patients with PAI caused by non-TAK diseases such as other types of vasculitis, fibrosing mediastinitis, pulmonary artery sarcoma, pulmonary sarcoidosis or chronic thromboembolic pulmonary hypertension","ALL","18 Years",{"count":46,"type":47},150,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).",[51,52],"Takayasu Arteritis With Pulmonary Artery Involvement","Pulmonary Arterial Hypertension Associated With Connective Tissue Disease","2025-09-19",{"date":55,"type":56},"2025-09-22","ACTUAL",{"date":58,"type":56},"2016-01-01",{"date":60,"type":47},"2026-12-31",{"name":5,"class":6},1]